Felice, Carla
 Distribuzione geografica
Continente #
NA - Nord America 1.409
EU - Europa 1.214
AS - Asia 862
SA - Sud America 161
AF - Africa 27
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.675
Nazione #
US - Stati Uniti d'America 1.373
DE - Germania 551
SG - Singapore 388
CN - Cina 224
SE - Svezia 144
BR - Brasile 124
FR - Francia 107
UA - Ucraina 95
IT - Italia 84
GB - Regno Unito 71
VN - Vietnam 70
IN - India 46
FI - Finlandia 39
IE - Irlanda 36
ID - Indonesia 31
CA - Canada 24
RU - Federazione Russa 24
JP - Giappone 19
TR - Turchia 17
AR - Argentina 16
BD - Bangladesh 16
PL - Polonia 14
BE - Belgio 12
ES - Italia 9
NL - Olanda 9
EC - Ecuador 7
HK - Hong Kong 6
IR - Iran 6
MX - Messico 6
ZA - Sudafrica 6
JM - Giamaica 5
MA - Marocco 5
AT - Austria 4
CI - Costa d'Avorio 4
IQ - Iraq 4
KR - Corea 4
PH - Filippine 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CO - Colombia 3
PK - Pakistan 3
SA - Arabia Saudita 3
UY - Uruguay 3
BH - Bahrain 2
CH - Svizzera 2
EG - Egitto 2
GR - Grecia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
TW - Taiwan 1
Totale 3.675
Città #
Chandler 227
Singapore 217
San Jose 138
Ashburn 131
Jacksonville 80
San Mateo 50
Beijing 49
Dearborn 47
New York 47
Ann Arbor 38
Nürnberg 37
Munich 36
Dublin 34
Cattolica 30
Nanjing 28
Jakarta 26
Lauterbourg 26
Los Angeles 25
Wilmington 25
Milan 20
Bremen 17
Hefei 17
Ho Chi Minh City 17
Boston 16
São Paulo 16
Dallas 15
Frankfurt am Main 15
Houston 15
Tokyo 15
Lawrence 14
Brussels 12
Lancaster 11
Hanoi 10
Helsinki 10
Izmir 10
Moscow 10
Turku 10
Warsaw 10
Buffalo 9
Princeton 9
Seattle 9
Toronto 9
Düsseldorf 8
Leawood 8
London 8
Nanchang 8
Rome 8
Detroit 7
Jiaxing 7
Paris 7
Redwood City 7
Haiphong 6
Hong Kong 6
Marseille 6
Montreal 6
Mountain View 6
Shanghai 6
Shenyang 6
Stockholm 6
Boardman 5
Brooklyn 5
Changsha 5
Denver 5
Hebei 5
San Francisco 5
The Dalles 5
Woodbridge 5
Abidjan 4
Andover 4
Ardabil 4
Augusta 4
Belo Horizonte 4
Calgary 4
Chennai 4
Curitiba 4
Da Nang 4
Dhaka 4
Fairfield 4
Guangzhou 4
Johannesburg 4
Mumbai 4
Orem 4
Phoenix 4
Redmond 4
Seoul 4
Tianjin 4
Amsterdam 3
Brasília 3
Casablanca 3
Costa Mesa 3
Duque de Caxias 3
Edinburgh 3
Hangzhou 3
Jinan 3
Kent 3
Kingston 3
Kunming 3
Manaus 3
Manila 3
Mexico City 3
Totale 1.861
Nome #
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 219
FOXP3⁺ T regulatory cell modifications in inflammatory bowel disease patients treated with anti-TNFα agents 209
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 197
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 190
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 189
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 188
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 188
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis 171
Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents 169
Ileal Crohn's disease: CEUS determination of activity 164
Use of infliximab in particular clinical settings: management based on current evidence. 154
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 152
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 133
Benefit–risk assessment of golimumab in the treatment of refractory ulcerative colitis 131
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases 128
Management of perianal fistulas in Crohn's disease: an up-to-date review 127
What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients? 123
Therapeutic drug monitoring is more cost-effective than a clinically-based approach in the management of loss of response to infliximab in inflammatory bowel disease: an observational multi-centre study. 111
AID in aging and autoimmune diseases 110
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 105
Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease 104
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 99
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 91
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 88
Acute cytomegalovirus infection as a possible trigger for pulmonary thromboembolism in a patient with steroid-refractory ulcerative colitis. 85
Biological therapies for inflammatory bowel disease: controversies and future options 76
Totale 3.701
Categoria #
all - tutte 13.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0 0 0 0 0 0 0 0 0 0 40 9
2021/2022237 27 17 4 39 4 3 3 47 7 4 30 52
2022/2023528 71 73 33 103 33 63 17 40 68 2 15 10
2023/2024244 10 50 6 20 3 50 3 33 10 12 24 23
2024/2025457 5 18 49 11 61 15 18 28 52 49 82 69
2025/20261.092 188 37 63 142 200 58 213 49 65 72 5 0
Totale 3.701